schizophrenia

Schizophrenia is a long-term mental health condition that causes a range of different psychological symptoms. These include: hallucinations (hearing or seeing things that do not exist), delusions (unusual beliefs that are not based on reality and often contradict the evidence), muddled thoughts based on the hallucinations or delusions, and changes in behaviour. Doctors describe schizophrenia as a psychotic illness. This means that sometimes a person may not be able to distinguish their own thoughts and ideas from reality.

Our schizophrenia Blogs

Scotland sees increase in prescribing rates for mental health drugs

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_57066451

The Scottish Government have published their annual summary of prescribing statistics for mental health drugs. The report shows increases in the prescribing rates for all groups of drugs over the last 12 months. The prescribing costs of some groups of drugs have also risen (ADHD, dementia, depression) although other groups have seen a decline (insomnia [read the full story…]

Making workplace adjustments for people with mental health problems: new guidance from the Department of Health

2 Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_98947130

There’s a growing body of evidence that shows how relatively minor adjustments in the workplace can have a huge impact on supporting people with mental health problems and help them stay in work. The Department of Health has published guidance that will help employers think through the changes that they can make in the workplace [read the full story…]

Short-term use of second-generation antipsychotics can cause side effects in children and adolescents

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_14019079

Over the last few years, we have seen more and more children and young people being prescribed antipsychotic drugs. The theory behind this increase is that the newer antipsychotic drugs have fewer side effects than the older typical antipsychotics. However, some small and relatively short duration studies have shown that the newer drugs may also [read the full story…]

CBT for people at ultra-high risk of psychosis: new RCT shows promise

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_16382851

Early intervention services for psychosis are aimed at people aged 14-35 who are experiencing a first episode of psychosis or at risk of doing so. The teams that work in this area usually include psychiatrists, psychologists, community psychiatric nurses, social workers and support workers. The NICE schizophrenia guideline recommends that early intervention services are offered [read the full story…]

New systematic review looking at emotional perception and social functioning in schizophrenia

No Responses »
Profile photo of Andre Tomlin
Posted by
emotions

People with schizophrenia often find it hard to do many of the day-to-day things that everyone else takes for granted. Simple tasks like eating healthily and washing can be challenging and more complex needs like developing relationships with other people and finding and holding down a job can seem like mountains to climb. Researchers refer [read the full story…]

Psychotic symptoms are associated with poorer health: findings from WHO survey

No Responses »
Profile photo of Andre Tomlin
Posted by
globe

The WHO World Health Survey is a comprehensive international survey carried out across 70 countries, which uses face-to-face, telephone and online interviews to ask questions about the health of populations, public health risk factors, coverage and availability of health services and health care spending. The survey includes a number of questions relating to mental health [read the full story…]

Psychosis and schizophrenia in children and young people: NICE starts consultation

2 Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_1586899

The two month consultation period for the new NICE guideline on psychosis and schizophrenia in children and young people has now begun. You must be registered as a stakeholder to comment on the guideline and you have until 27th September 2012 to make your views known. The guideline is aimed at clinicians and service commissioners [read the full story…]

The risks of benzodiazepines, antidepressants and antipsychotics in adults with schizophrenia

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_71903914

Polypharmacy is the simultaneous use of two or more drugs to treat a single health condition. Polypharmacy is often used in the treatment of schizophrenia where people are regularly prescribed two or more antipsychotics, as well as antidepressants and/or benzodiazepines, although there is little evidence to prove that these combinations are more effective than monotherapy. [read the full story…]

Losing weight on antipsychotics. New systematic review looks at diet and exercise

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_85333330

Weight gain is one of the side effects that people who take antipsychotic drugs complain of the most. Obesity is common in this population and this can often lead to cardiovascular problems and a far shorter life expectancy than the rest of the population. As a result, there is a great deal of interest in [read the full story…]

Paliperidone palmitate injections for schizophrenia: new Cochrane systematic review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_79355929

We know that people with schizophrenia who adhere to their treatment are more likely to experience sustained periods of time without psychotic symptoms. However, lots of patients find it hard to stick to the prescribed medication, so doctors sometimes recommend alternative treatments to try and encourage adherence. Long-acting intramuscular injections are one option available to [read the full story…]